Poxel receives Chinese patent for use of Imeglimin for type-2 diabetic patients with renal impairment: Lyon, France Wednesday, January 22, 2025, 18:00 Hrs [IST] Poxel SA, a clinic ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...
IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...
Obstructed Defecation Syndrome (ODS) is a complex medical disorder mainly due to a combination of mechanical and functional issues in the anorectal area.
Rigel Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of escalating doses of fostamatinib, the company's oral ...